The International Society of Bilateral Cataract Surgery holds inaugural meeting during ESCRS
November 1st 2008The inaugural meeting of the International Society of Bilateral Cataract Surgeons (ISBCS) was held Sept. 1, during the recent annual meeting of the European Society of Cataract and Refractive Surgeons (ESCRS).
Sun, anti-oxidant may predict age-related macular degeneration risk
November 1st 2008A combination of blue light exposure and low blood levels of anti-oxidants may be associated with an increased risk of neovascular age-related macular degeneration (AMD), as well as early AMD, according to research published in the October issue of Archives of Ophthalmology.
HIV drugs needed globally to control disease long term
November 1st 2008Human immunodeficiency virus (HIV) has become a manageable chronic disease, but that is true only in rich countries that have a relatively small number of HIV cases. With the evolution of treatment, patients can expect a natural life expectancy with the available therapies. These treatments are needed globally in third-world countries where most of the cases are.
U.S. patent issued on new class of compounds to treat AMD
October 29th 2008A U.S. patent has been granted to a pharmaceuticals company that will cover a broad class of disubstituted hydroxylamine small molecules that target oxidative stress and inflammation pathways believed to be involved in age-related macular degeneration (AMD) and other ophthalmic diseases.
AAO 2008 Meeting Preview and Podcast
October 28th 2008In this podcast, Ophthalmology Times Chief Medical Editor Peter J. McDonnell, MD, provides an overview of the AAO meeting, including the hottest topics that will be discussed. Also, Ophthalmology Times Associate Editor Christina Phillis provides tips on traveling to and getting the most of your time in Atlanta. Daily podcast coverage will feature session highlights and interviews with highly regarded specialists in ophthalmologic medicine.
AMD drug's phase I results to be presented at AAO
October 28th 2008A biotechnology company will be presenting its ASaP phase I clinical data for its leading drug candidate (POT-4, Potentia Pharmaceuticals) during Retina Subspecialty Day at the annual meeting of the American Academy of Ophthalmology in Atlanta Nov. 7.
Convergence insufficiency therapy responds best to office-based treatment
October 23rd 2008Children with convergence insufficiency improved significantly more with office-based treatment plus home reinforcement compared with home-based or placebo office therapy, according to a study published in the October issue of Archives of Ophthalmology.
Low antioxidant levels and exposure to sunlight likely to damage vision
October 22nd 2008The combination of low antioxidant levels and exposure to sunlight may damage vision and also is linked to age-related macular degeneration, according to a study published in the October issue of the Archives of Ophthalmology.
Sirion Therapeutics launches corticosteroid for postoperative ocular inflammation and pain
October 15th 2008Sirion Therapeutics Inc. announced that a difluprednate ophthalmic emulsion 0.05% (Durezol) indicated for the treatment of inflammation and pain associated with ocular surgery is now commercially available.
Viscoelastic receives FDA approval
October 15th 2008Advanced Medical Optics (AMO) announced that the FDA has granted premarket approval of a viscoelastic (Healon D), a clear dispersive ophthalmic viscosurgical device (OVD) for use as a surgical aid in cataract extraction, IOL implantation, corneal transplant, and glaucoma filtration surgery.
Bascom Palmer gains top spot in annual survey
October 15th 2008The Bascom Palmer Eye Institue, University of Miami School of Medicine, sweeps three categories-Best Overall, Best Residency, and Best Clinical (Patient Care) Programs-in the 13th annual Ophthalmology Times' Best Programs survey. The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, takes the top honors for Best Research Program. Chairpersons and residency directors from U.S. departments of ophthalmology ranked programs nationwide.
Telemedicine: well-established in ROP
October 15th 2008The value of telemedicine is well established, but some limitations in image quality do exist. An objective evaluation of the images overrides the limitations, however. Imaging provides a great opportunity for research. More data on cost effectiveness of various screening modalities are needed in patients with retinopathy of prematurity.
Demands: Striving for sense of balance in personal and professional lives
October 15th 2008Ophthalmic practice administrators often find heavy demands on their time and attention and so, like many managers, risk losing sight of what's important in the rest of their lives. But while it isn't possible to avoid the stresses and strains that accompany the job, there are ways administrators can maintain or restore a sense of balance in their lives.
Details key to increasing patient volume, maintaining ophthalmic business
October 15th 2008Reimbursements for ophthalmic practices are steadily declining while costs are going ever higher, leaving practices scrambling as never before to find new sources of revenue and ways of cutting costs. But unless these goals are approached wisely they can lead to stress among both staff and doctor.
2008's new modifiers should be used correctly
October 15th 2008Current Procedural Terminology (CPT) is updated regularly, often in response to difficulties reported by practitioners. Practices that fail to keep up with the changes experience negative consequences on revenue and compliance. Staying familiar with changes in CPT can be very useful, and potentially quite rewarding.